On-demand portal and report walkthrough
23andMe’s New Pharmacogenetics Portal and Summary Report for Healthcare Professionals

This month, 23andMe launched a new Pharmacogenetics Portal for Healthcare Professionals. The portal was designed to help providers understand how to utilize our new FDA-authorized Pharmacogenetics* reports. The site contains educational information including links to clinically established guidelines and FDA label information, to help HCPs consider the next steps with their patient. Additionally, the portal complements the Pharmacogenetics Summary Report (intended for healthcare professionals) that customers receive when they view their Pharmacogenetics reports.*

Both the portal and the summary report are a part of the larger 23andMe Pharmacogenetics reports launch, which was released to a subset of 23andMe customers who have opted-in to receive health reports.

Available now, is an on-demand walkthrough of the Pharmacogenetics summary report and Pharmacogenetics Portal for Healthcare Professionals. Sample reports for different report outcomes in addition to the Pharmacogenetics Summary report are located under the ‘Reports’ tab on our Healthcare Professionals website.

Register now

This report walkthrough is intended for healthcare professionals.  

About the speaker:

Alison Chubb, PhD

Product Science

Alison has worked at 23andMe since 2013 and is part of the team that envisions, designs, and implements genetic health reports.

Alison earned her BA from Princeton University and her PhD in Integrative Biology from the University of California, Berkeley.

*The 23andMe PGS test uses qualitative genotyping to detect 6 variants in 3 genes in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Results should be confirmed in a clinical setting with independent genetic testing before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For a complete list of the 6 variants tested, visit https://permalinks.23andme.com/pdf/pgt_product_info_page_21jan2020.pdf.